• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

FASEB J . Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice

tetano

Editor, Senior Moderator
FASEB J


. 2021 Sep;35(9):e21801.
doi: 10.1096/fj.202002742RR.
Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice


Xiaoling Cao[SUP] 1 [/SUP], Yan Tian[SUP] 1 2 [/SUP], Vi Nguyen[SUP] 1 [/SUP], Yuping Zhang[SUP] 1 3 [/SUP], Chao Gao[SUP] 1 [/SUP], Rong Yin[SUP] 1 [/SUP], Wayne Carver[SUP] 1 4 [/SUP], Daping Fan[SUP] 1 4 [/SUP], Helmut Albrecht[SUP] 5 6 [/SUP], Taixing Cui[SUP] 1 4 [/SUP], Wenbin Tan[SUP] 1 4 [/SUP]



Affiliations

Abstract

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a crucial role in mediating viral entry into host cells. However, whether it contributes to pulmonary hyperinflammation in patients with coronavirus disease 2019 is not well known. In this study, we developed a spike protein-pseudotyped (Spp) lentivirus with the proper tropism of the SARS-CoV-2 spike protein on the surface and determined the distribution of the Spp lentivirus in wild-type C57BL/6J male mice that received an intravenous injection of the virus. Lentiviruses with vesicular stomatitis virus glycoprotein (VSV-G) or with a deletion of the receptor-binding domain (RBD) in the spike protein [Spp (∆RBD)] were used as controls. Two hours postinfection (hpi), there were 27-75 times more viral burden from Spp lentivirus in the lungs than in other organs; there were also about 3-5 times more viral burden from Spp lentivirus than from VSV-G lentivirus in the lungs, liver, kidney, and spleen. Deletion of RBD diminished viral loads in the lungs but not in the heart. Acute pneumonia was observed in animals 24 hpi. Spp lentivirus was mainly found in SPC[SUP]+[/SUP] and LDLR[SUP]+[/SUP] pneumocytes and macrophages in the lungs. IL6, IL10, CD80, and PPAR-γ were quickly upregulated in response to infection in the lungs as well as in macrophage-like RAW264.7 cells. Furthermore, forced expression of the spike protein in RAW264.7 cells significantly increased the mRNA levels of the same panel of inflammatory factors. Our results demonstrated that the spike protein of SARS-CoV-2 confers the main point of viral entry into the lungs and can induce cellular pathology. Our data also indicate that an alternative ACE2-independent viral entry pathway may be recruited in the heart and aorta.

Keywords: COVID-19; SARS-CoV-2; inflammation; lung; spike.
 
Back
Top Bottom